Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Mouth Neoplasms 3Carcinoma, Renal Cell 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Breast Neoplasms 2Urinary Tract Infections 1Tongue Neoplasms 1Tobacco Use Disorder 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Mouth Diseases 1Lymphoid Interstitial Pneumonia 1Lymphatic Metastasis 1Lung Neoplasms 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Klatskin Tumor 1Fanconi Anemia 1Erythroplasia 1Colonic Polyps 1Colonic Neoplasms 1Colonic Diseases 1Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 677130-nm albumin-bound paclitaxel 197Fluorouracil 184Oxaliplatin 173Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 129Irinotecan 111Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 71Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 48Magnetic Resonance Spectroscopy 45folfirinox 42Docetaxel 41Cetuximab 40irinotecan sucrosofate 36Specimen Handling 36S 1 (combination) 36Biopsy 30Radiation 29Paclitaxel 29Ipilimumab 27Surgical Procedures, Operative 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Optical Imaging × Clear all
NCT03033225 2025-07-30

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Mayo Clinic

Phase 2 Completed
13 enrolled 6 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡